Pharmaceutical kit

Information

  • Patent Grant
  • D457246
  • Patent Number
    D457,246
  • Date Filed
    Monday, December 20, 1999
    25 years ago
  • Date Issued
    Tuesday, May 14, 2002
    23 years ago
  • US Classifications
    Field of Search
    • US
    • D24 225
    • D24 226
    • D24 223
    • D09 345
    • D09 340
    • D20 40
    • 206 532
    • 206 5341
    • 206 5342
    • 206 531
    • D03 203
  • International Classifications
    • 2402
    • Term of Grant
      14Years
Abstract
Description




FIG. 1 is an exploded perspective view, on a reduced scale, of a pharmaceutical kit showing our new design in the fully unfolded position with an uninserted insert card;




FIG. 2 is a full scale front plan view thereof;




FIG. 3 is a full scale end elevational view thereof;




FIG. 4 is a full scale rear plan view thereof;




FIG. 5 is a full scale right end elevational view thereof;




FIG. 6 is a full scale left end elevational view thereof;




FIG. 7 is a full scale front plan view of the insert card of the pharmaceutical kit shown in FIG. 1;




FIG. 8 is a full scale rear plan view of the insert card of the pharmaceutical kit shown in FIG. 1;




FIG. 9 is a full scale side elevational view of the insert card of the pharmaceutical kit shown in FIG. 1;




FIG. 10 is a full scale end elevational view of the insert card of the pharmaceutical kit shown in FIG. 1;




FIG. 11 is a full scale perspective view of the pharmaceutical kit shown in FIG. 1 in the fully folded position; and,




FIG. 12 is an exploded perspective view, on a reduced scale, in the fully unfolded position with a partially inserted insert card.



Claims
  • The ornamental design for a pharmaceutical kit, as shown and described.
US Referenced Citations (29)
Number Name Date Kind
3504788 Gray Apr 1970 A
3527190 Huck Sep 1970 A
3677397 Beckham Jul 1972 A
4199569 Chabala et al. Apr 1980 A
4243144 Margulies Jan 1981 A
4295567 Knudsen Oct 1981 A
4340141 Du Pont Jul 1982 A
4425339 Pitchford Jan 1984 A
4506789 Dlugosz Mar 1985 A
4534468 Nuckols et al. Aug 1985 A
4573580 Messer Mar 1986 A
4736849 Leonard et al. Apr 1988 A
4761406 Flora et al. Aug 1988 A
4848582 Levasseur et al. Jul 1989 A
4889237 Brandon Dec 1989 A
4889238 Batchelor Dec 1989 A
4974729 Steinnagel Dec 1990 A
5050739 Hannan et al Sep 1991 A
5242055 Pora Sep 1993 A
5265728 Allendorf et al. Nov 1993 A
5339960 Price Aug 1994 A
5393100 Coc Feb 1995 A
RE35445 Pora Feb 1997 E
5755462 Lupi May 1998 A
5833072 Lambelet, Jr. Nov 1998 A
5915559 Hulick et al. Jun 1999 A
5927500 Godfrey et al. Jul 1999 A
5994329 Daifotis et al. Nov 1999 A
6024222 Friberg et al. Feb 2000 A
Foreign Referenced Citations (10)
Number Date Country
866616 Mar 1971 CA
0 511 726 Nov 1992 EP
2635507 Feb 1990 FR
1580583 Dec 1980 GB
2256853 Dec 1992 GB
WO 9703896 Feb 1997 WO
WO 9800351 Jan 1998 WO
WO 9822072 May 1998 WO
WO 9904773 Feb 1999 WO
WO 9951214 Oct 1999 WO
Non-Patent Literature Citations (5)
Entry
Greenberg, Clin. Therap., vol. 6 (1984), “Overview of patient compliance with medication dosing: A literature Review”, pp. 592-599.
Schnitzer et al., Aging Clin. Exp. Res., vol. 12 (2000), pp. 1-12, “Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis”.
Adami et al., 6th Int'l Symposium on Clinical Disorders of Bone and Mineral Metabolism, Nov. 1999, “Rationale for once weekly dosing regimens with alendronate for the treatment and prevention of osteoporosis”, p. 48.
Bone III et al., 6th Int'l Symposium on Clinical Disorders of Bone and Mineral Metabolism, Nov. 1999 ,“Alendronate 70 mg once weekly is therapeutically equivalent to alendronate 10 mg daily”, p. 55.
Copy of dispenser package and insert for Heartgard 30® (ivermectin) chewables, Merck & Co., Inc., Oct. 1988.